Rebirthel Co., Ltd.
PrivateLast Round
Series B
Dec 1, 2022
Total Funding Raised
$1.7M
Company Overview
Rebirthel Co., Ltd. is a biotechnology company that develops allogeneic T-cell immunotherapies using iPS cells to treat cancer and other immune-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebirthel Co., Ltd. Comparables
Compare Rebirthel Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 83% | |
| Cartherics | 83% | |
| Neukio Biotherapeutics | 83% | |
Rebirthel Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2022 | ||||
| Seed | Mar 30, 2020 |
Key People
Founding team and executive leadership
Rebirthel Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chushin Venture Capital | Series B |
| 株式会社ヘルスケア・イノベーション | Series B |
| Kagawa Securities Co., Ltd. | Series B |
| Nissei Capital | Series B |
| Japan Science and Technology Agency | Seed, Series B |
| Fujifilm Corporation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2025
Partnering with Eutilex to develop next-generation CAR-T therapies.
- Mar 30, 2020
Secured funding from Japan Science and Technology Agency.
Rebirthel Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rebirthel Co., Ltd.'s valuation, stock price, and market status.